Keying Ma

897 total citations
10 papers, 396 citations indexed

About

Keying Ma is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Keying Ma has authored 10 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Keying Ma's work include Helicobacter pylori-related gastroenterology studies (5 papers), Inflammatory Bowel Disease (5 papers) and Microscopic Colitis (2 papers). Keying Ma is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (5 papers), Inflammatory Bowel Disease (5 papers) and Microscopic Colitis (2 papers). Keying Ma collaborates with scholars based in United States, Belgium and Canada. Keying Ma's co-authors include Roy L. Silverstein, Keith R. McCrae, Ronit Simantov, Katherine A. Hajjar, Frédéric Baribaud, Katherine Li, Gary Toedter, Paul Rutgeerts, Colleen Marano and Sarah Sague and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Keying Ma

9 papers receiving 390 citations

Peers

Keying Ma

IMMUN

RHEUM

HEMAT

GENET

Francisca C. Gushiken United States

Keiichi Iwanami Japan

Nadine Müller‐Calleja Germany

Boaz Palterer Italy

Roberta Hanna United States

Rie Masai Japan

Sarah Sague United States

Iván Posso‐Osorio Colombia

Ye‐Sheng Wei China

Alfonso Principato Italy

Francisca C. Gushiken United States

Keying Ma

180 ×1.2

IMMUN

50 ×0.3

RHEUM

210 ×2.0

HEMAT

71 ×0.7

GENET

123 ×1.4

Citations per year, relative to Keying Ma Keying Ma (= 1×) peers Francisca C. Gushiken

Countries citing papers authored by Keying Ma

Since Specialization

Citations

This map shows the geographic impact of Keying Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keying Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keying Ma more than expected).

Fields of papers citing papers by Keying Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keying Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keying Ma. The network helps show where Keying Ma may publish in the future.

Co-authorship network of co-authors of Keying Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Keying Ma. A scholar is included among the top collaborators of Keying Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keying Ma. Keying Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Blauvelt, Andrew, Richard G. Langley, Patrick Branigan, et al.. (2024). Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy. SHILAP Revista de lepidopterología. 4(5). 100287–100287. 3 indexed citations

Sweet, Kristen, Qingxuan Song, Matthew J. Loza, et al.. (2021). Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials. RMD Open. 7(2). e001679–e001679. 32 indexed citations

Jordan, Jarrat, Kristen Sweet, Matteo Cesaroni, et al.. (2019). 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus. Abstracts. A185.1–A185.

Li, Katherine, Shannon Telesco, Paul Rutgeerts, et al.. (2013). Su1745 Characterization of Molecular Response to Golimumab in Ulcerative Colitis by mRNA Expression Profiling: Results From Pursuit-SC Induction Study. Gastroenterology. 144(5). S–465. 2 indexed citations

Li, Katherine, Carrie Brodmerkel, Shannon Telesco, Keying Ma, & Christopher Gasink. (2013). 978 Whole Blood mRNA Expression Profiling of Crohn's Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes. Gastroenterology. 144(5). S–179. 1 indexed citations

Toedter, Gary, Katherine Li, Sarah Sague, et al.. (2012). Genes Associated with Intestinal Permeability in Ulcerative Colitis: Changes in Expression Following Infliximab Therapy. Inflammatory Bowel Diseases. 18(8). 1399–1410. 38 indexed citations

Toedter, Gary, Katherine Li, Colleen Marano, et al.. (2011). Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis. The American Journal of Gastroenterology. 106(7). 1272–1280. 79 indexed citations

Judson, Marc A., Richard Marchell, Elliot S. Barnathan, et al.. (2011). Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway. Journal of the American Academy of Dermatology. 66(6). 901–910.e2. 58 indexed citations

Toedter, Gary, Keying Ma, Katherine Li, et al.. (2010). W1228 Genes Associated With Reduced Epithelial Permeability and Epithelial-Mesenchymal Transition: Changes in Expression Following Infliximab Therapy in Ulcerative Colitis. Gastroenterology. 138(5). S–679. 1 indexed citations

10.

Ma, Keying, et al.. (2000). High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II. Journal of Biological Chemistry. 275(20). 15541–15548. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact